Wallner K - Search Results

1

Wallner K, Kearney KK, Lombardi WL, Kim M. Wallner K, et al. Brachytherapy. 2022 May-Jun;21(3):347-353. doi: 10.1016/j.brachy.2021.12.003. Epub 2022 Jan 31. Brachytherapy. 2022. PMID: 35101358

2

Radiation safety parameters following prostate brachytherapy.

Smathers S, Wallner K, Korssjoen T, Bergsagel C, Hudson RH, Sutlief S, Blasko J. Smathers S, et al. Among authors: wallner k. Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):397-9. doi: 10.1016/s0360-3016(99)00168-6. Int J Radiat Oncol Biol Phys. 1999. PMID: 10487562

3

Treatment margins for prostate brachytherapy.

Han B, Wallner K, Aggarwal S, Armstrong J, Sutlief S. Han B, et al. Among authors: wallner k. Semin Urol Oncol. 2000 May;18(2):137-41. Semin Urol Oncol. 2000. PMID: 10875455

4

Prostate brachytherapy in patients with median lobe hyperplasia.

Wallner K, Smathers S, Sutlief S, Corman J, Ellis W. Wallner K, et al. Int J Cancer. 2000 Jun 20;90(3):152-6. Int J Cancer. 2000. PMID: 10900427

5

Argon plasma coagulation for rectal bleeding after prostate brachytherapy.

Smith S, Wallner K, Dominitz JA, Han B, True L, Sutlief S, Billingsley K. Smith S, et al. Among authors: wallner k. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):636-42. doi: 10.1016/s0360-3016(01)01704-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11597803

6

Clinical correlates of high intraprostatic brachytherapy dose volumes.

Jones S, Wallner K, Merrick G, Corriveau J, Sutlief S, True L, Butler W. Jones S, et al. Among authors: wallner k. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):328-33. doi: 10.1016/s0360-3016(02)02741-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023136 Clinical Trial.

7

Isodose patterns in patients with inadequate prostate brachytherapy coverage.

Reed DR, Wallner KE, Merrick G, Butler W, Han BH, Sutlief SG, Cho PS. Reed DR, et al. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1480-7. doi: 10.1016/s0360-3016(03)00527-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 12873693

8

Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Kurko B, Cleavinger S. Merrick GS, et al. Brachytherapy. 2003;2(3):147-57. doi: 10.1016/S1538-4721(03)00131-4. Brachytherapy. 2003. PMID: 15062137 Clinical Trial.

9

Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Lief JH, Hinerman-Mulroy A, Galbreath RW. Merrick GS, et al. Brachytherapy. 2003;2(3):181-8. doi: 10.1016/S1538-4721(03)00130-2. Brachytherapy. 2003. PMID: 15062141

10

Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.

Corriveau J, Wallner K, Merrick G, True L, Cavanagh W, Sutlief S, Butler W. Corriveau J, et al. Among authors: wallner k. Brachytherapy. 2003;2(2):108-13. doi: 10.1016/S1538-4721(03)00099-0. Brachytherapy. 2003. PMID: 15062149 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters